Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02922959 · ClinicalTrials.gov registry record · NA
A Tailored, Peer-delivered Intervention to Reduce Recurring Opioid Overdoses
A NA study, sponsored by University of Cincinnati.
- Completed
- Registry status
- NA
- Development phase
- 80
- Enrollment target
NCT02922959: Completed NA study, sponsored by University of Cincinnati.
NCT02922959 is a NA study that has completed, run by University of Cincinnati. The registered enrollment target is 80 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02922959, a NA study, has completed, sponsored by University of Cincinnati.
- COMPLETED
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
Study Summary
This project will further develop and test the Tailored Telephone Intervention delivered by Peers to Prevent Recurring Opioid Overdoses (TTIP-PRO), a promising, low-cost, intervention to facilitate entry into medication assisted treatment (MAT) for individuals experiencing a non-fatal opioid overdoses (OOD). A prior small-scale pilot/feasibility study of TTIP-PRO (NCT02282306) found that the participating patients and the Peer Interventionists were satisfied with their participation, the intervention was acceptable, and the system for generating patient-tailored intervention information performed well. The overall goal of the present study is to conduct a pilot randomized controlled trial of TTIP-PRO versus a control group. It is hypothesized that patients in the TTIP-PRO group will have more favorable drug-abuse-related outcomes than patients in the control group.
Primary Outcome
whether or not participant enrolled in medication-assisted treatment within the follow-up period
Interventions
- BEHAVIORAL Peer Intervention
- DRUG naloxone nasal spray kit
- BEHAVIORAL Personally-tailored opioid overdose prevention education (information packet)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2017-02-07 |
| Est. Completion | 2019-07-25 |
| Phase | NA |
What the finished NCT02922959 record still lists
NCT02922959 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).
The record links to 0 conditions, and to 3 interventions - of which Peer Intervention is the first listed.
NCT02922959 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02922959 about?
NCT02922959 is a clinical study titled "A Tailored, Peer-delivered Intervention to Reduce Recurring Opioid Overdoses". This project will further develop and test the Tailored Telephone Intervention delivered by Peers to Prevent Recurring Opioid Overdoses (TTIP-PRO), a promising, low-cost, intervention to facilitate entry into medication assisted treatment (MAT) for individuals experiencing a non-fatal opioid overdos...
What is the current status of trial NCT02922959?
This trial is currently completed. It is a NA study. The enrollment target is 80 participants. The study started on 2017-02-07. Estimated completion is 2019-07-25.
What interventions are being tested in trial NCT02922959?
The interventions under investigation include: Peer Intervention (BEHAVIORAL), naloxone nasal spray kit (DRUG), Personally-tailored opioid overdose prevention education (information packet) (BEHAVIORAL).
Who is sponsoring clinical trial NCT02922959?
This trial is sponsored by University of Cincinnati, which has 245 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02922959's enrollment target sits among peer trials
80 994th of 2000 higher than 941 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI